Literature DB >> 27842710

[Hypertension and coronary artery disease: New concept?]

G Lefèvre1, E Puymirat2.   

Abstract

Hypertension is the most important preventable cause of heart disease and stroke worldwide. More than 1 in 5 adults worldwide have raised blood pressure - a condition that causes around half of all deaths from stroke and heart disease. Complications from hypertension account for 9.4 million deaths worldwide every year. During the last decade, the association between blood pressure reduction from above-normal initial values and cardiovascular-risk has been documented in a large number of randomized trials. However, recent results from the SPRINT study could challenge current therapeutic strategies. This article is a literature review about the relationship between hypertension and coronary artery disease.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cardiopathie ischémique; Cardiovascular risk factors; Coronaropathie; Coronary artery disease; Facteurs de risque cardiovasculaire; Hypertension; Hypertension artérielle; Ischemic heart disease

Mesh:

Year:  2016        PMID: 27842710     DOI: 10.1016/j.ancard.2016.10.011

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  3 in total

1.  Study on the correlation between Left Ventricular Hypertrophy and Coronary Artery disease in the very elderly patients with hypertension.

Authors:  Jian-Hua Sun; Xiao-Kun Liu; Qi Zhang; Qing-Hua Zhang
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

2.  Post-operative blood pressure and 3-year major adverse cardiac events in Chinese patients undergoing PCI.

Authors:  Lijun Gan; Dandan Sun; Yuntao Cheng; Deyang Wang; Fen Wang; Lin Wang; Wei Li; Dandan Shen; Daotong Guo; Zonglei Zhang; Haiyan Wang; Jinli Li; Yong Yang; Tao Liang
Journal:  BMC Cardiovasc Disord       Date:  2021-12-30       Impact factor: 2.298

3.  The genetic polymorphisms of ZC3HC1 and SMARCA4 are associated with hypertension risk.

Authors:  Huijun Ma; Yongjun He; Mei Bai; Linhao Zhu; Xue He; Li Wang; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2019-09-10       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.